Detection of the novel HLA-A*29:183 allele in a Russian individual.
Autorzy:
Ananeva A; Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation. Kadirov A; Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation. Andryushkina AV; National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation. Shagimardanova EI; Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.; Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation.
Pokaż więcej
Źródło:
HLA [HLA] 2024 Jan; Vol. 103 (1), pp. e15304. Date of Electronic Publication: 2023 Nov 22.
Base-editing mutagenesis maps alleles to tune human T cell functions.
Autorzy:
Schmidt R; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. .; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. . Ward CC; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. . Dajani R; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Armour-Garb Z; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Ota M; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA. Allain V; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Université Paris Cité, INSERM UMR976, Hôpital Saint-Louis, Paris, France. Hernandez R; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Layeghi M; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Xing G; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA. Goudy L; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Dorovskyi D; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. Wang C; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Biomedical Sciences Graduate Program, University of California, San Francisco, CA, USA. Chen YY; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Ye CJ; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Institute for Human Genetics (IHG), University of California, San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA. Shy BR; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. Gilbert LA; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, USA.; Arc Institute, Palo Alto, CA, USA. Eyquem J; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Institute for Human Genetics (IHG), University of California, San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. Pritchard JK; Department of Genetics, Stanford University, Stanford, CA, USA.; Department of Biology, Stanford University, Stanford, CA, USA. Dodgson SE; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. Marson A; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. .; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. .; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. .; Institute for Human Genetics (IHG), University of California, San Francisco, San Francisco, CA, USA. .; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. .; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. .; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA. .; Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2024 Jan; Vol. 625 (7996), pp. 805-812. Date of Electronic Publication: 2023 Dec 13.
MSL2 ensures biallelic gene expression in mammals.
Autorzy:
Sun Y; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Wiese M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Hmadi R; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Karayol R; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Seyfferth J; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Martinez Greene JA; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany. Erdogdu NU; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany. Deboutte W; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Arrigoni L; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Holz H; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Renschler G; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Hirsch N; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Foertsch A; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany. Basilicata MF; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Stehle T; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Shvedunova M; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Bella C; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Pessoa Rodrigues C; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Schwalb B; Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany. Cramer P; Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany. Manke T; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Akhtar A; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Dec; Vol. 624 (7990), pp. 173-181. Date of Electronic Publication: 2023 Nov 29.
Next-generation HLA sequencing reveals the novel HLA-DPB1*1492:01 allele.
Autorzy:
Gvozdjan K; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA. Cheline J; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA. Dastych K; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA. Wirtz C; Global Technical Support and Training, CareDx, Inc., Brisbane, California, USA. Gaitonde S; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Nov; Vol. 102 (5), pp. 648-650. Date of Electronic Publication: 2023 Jul 29.
Characterization of the novel HLA-DQA1*01:64:02 allele by sequencing-based typing.
Autorzy:
Blandin L; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Visentin J; Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, CHU de Bordeaux, Bordeaux, France.; CNRS, ImmunoConcEpT, UMR 5164, University of Bordeaux, Bordeaux, France. Cargou M; Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, CHU de Bordeaux, Bordeaux, France.; CNRS, ImmunoConcEpT, UMR 5164, University of Bordeaux, Bordeaux, France. Rouzaire P; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.; EA(UR)7453 CHELTER, Clermont-Auvergne University, Clermont-Ferrand, France. Lemal R; Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.; EA(UR)7453 CHELTER, Clermont-Auvergne University, Clermont-Ferrand, France.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Sep; Vol. 102 (3), pp. 380-381. Date of Electronic Publication: 2023 May 19.
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
Autorzy:
Augusto DG; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.; Department of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC, USA.; Programa de Pós-Graduação em Genética, Universidade Federal do Paraná, Curitiba, Brazil. Murdolo LD; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia. Chatzileontiadou DSM; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Sabatino JJ Jr; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. Yusufali T; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. Peyser ND; Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA. Butcher X; Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA. Kizer K; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. Guthrie K; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. Murray VW; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Pae V; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Sarvadhavabhatla S; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Beltran F; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Gill GS; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Lynch KL; Department of Laboratory Medicine, University of California, San Francisco, CA, USA. Yun C; Department of Laboratory Medicine, University of California, San Francisco, CA, USA. Maguire CT; Clinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA. Peluso MJ; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Hoh R; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Henrich TJ; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Deeks SG; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Davidson M; Department of Medicine, University of California, San Francisco, CA, USA. Lu S; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Goldberg SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.; F.I. Proctor Foundation, University of California, San Francisco, CA, USA. Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Vierra-Green CA; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA. Spellman SR; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA. Langton DJ; ExplantLab, Newcastle-upon-Tyne, UK. Dewar-Oldis MJ; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia. Smith C; QIMR Berghofer Centre for Immunotherapy and Vaccine Development Brisbane, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Barnard PJ; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia. Lee S; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA. Marcus GM; Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA. Olgin JE; Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA. Pletcher MJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.; Division of General Internal Medicine, University of California, San Francisco, CA, USA. Maiers M; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA. Gras S; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Hollenbach JA; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA. .; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Aug; Vol. 620 (7972), pp. 128-136. Date of Electronic Publication: 2023 Jul 19.
Identification of two novel HLA-DQB1*03:01:01 intronic variants: HLA-DQB1*03:01:01:47 and -DQB1*03:01:01:48.
Autorzy:
Gil Etayo FJ; Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Niño Ramírez JE; Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Universidad de Salamanca (USAL), Salamanca, Spain. Vicente Parra A; Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain. García Sanz R; Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Universidad de Salamanca (USAL), Salamanca, Spain.; Centro de Investigación del Cáncer (CIC), Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain. Tejeda Velarde A; Laboratorio de HLA-Biología Molecular, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
Pokaż więcej
Źródło:
HLA [HLA] 2023 May; Vol. 101 (5), pp. 562-564. Date of Electronic Publication: 2022 Dec 27.
A thermosensitive PCNA allele underlies an ataxia-telangiectasia-like disorder.
Autorzy:
Magrino J; Department of Biochemistry and Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Munford V; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Martins DJ; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Homma TK; Genetic Endocrinology Unit, Cellular and Molecular Endocrinology Laboratory LIM25, Endocrinology Discipline of the Faculty of Medicine of the University of São Paulo, São Paulo, Brazil; Developmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM42, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil. Page B; Department of Biochemistry and Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Gaubitz C; Department of Biochemistry and Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Freire BL; Genetic Endocrinology Unit, Cellular and Molecular Endocrinology Laboratory LIM25, Endocrinology Discipline of the Faculty of Medicine of the University of São Paulo, São Paulo, Brazil; Developmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM42, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil. Lerario AM; Developmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM42, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA. Vilar JB; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Amorin A; Neurogenetics, Neurology Department, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil. Leão EKE; Medical Genetics Service of the Professor Edgard Santos University Hospital - Federal University of Bahia, Salvador, Brazil. Kok F; Neurogenetics, Neurology Department, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil; Mendelics Genomic Analysis, São Paulo, São Paulo, Brazil. Menck CF; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Jorge AA; Genetic Endocrinology Unit, Cellular and Molecular Endocrinology Laboratory LIM25, Endocrinology Discipline of the Faculty of Medicine of the University of São Paulo, São Paulo, Brazil. Kelch BA; Department of Biochemistry and Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Electronic address: .
The novel HLA-C*06:372 allele, identified in a stem cell donor of an old order mennonite ethnicity.
Autorzy:
Beaune D; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Sharma A; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Cohoe E; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Al Agbar S; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Sidahmed AME; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada.
A novel HLA-C*02:10 variant, HLA-C*02:10:09, identified in a healthy individual from Brazil.
Autorzy:
Stelet VN; Immunogenetics Laboratory, National Cancer Institute, Rio de Janeiro, Brazil. Romero M; Immunogenetics Laboratory, National Cancer Institute, Rio de Janeiro, Brazil. Cita RF; Transplant Immunology Laboratory, Pio XII Foundation, Barretos, Brazil. Binato R; Immunogenetics Laboratory, National Cancer Institute, Rio de Janeiro, Brazil. Abdelhay E; Immunogenetics Laboratory, National Cancer Institute, Rio de Janeiro, Brazil.
Next-generation sequencing identifies two novel HLA-DPB1 alleles: HLA-DPB1*1069:01 and DPB1*1072:01.
Autorzy:
Misra MK; Department of Pathology, The University of Chicago Medicine, Chicago, Illinois, USA. Brown NK; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Marino SG; Department of Pathology, The University of Chicago Medicine, Chicago, Illinois, USA.
The novel HLA-DRB1*08:127 allele, identified in a deceased organ donor of Scandinavian descent.
Autorzy:
Sharma A; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Beaune D; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Fielder D; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Al Agbar S; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada. Sidahmed AME; Immunogenetics and Transplantation Laboratory, London Health Sciences Centre and Pathology and Laboratory Medicine, University Hospital, London, Ontario, Canada.
Recruiting refugees and migrants as potential hematopoietic stem cell donors to serve patients of comparable ethnicities with rare human leucocyte antigen patterns - The BluStar.NRW project in North Western Germany.
Autorzy:
Heinemann FM; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Electronic address: . Baumgart C; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Binder C; Westdeutsche SpenderZentrale WSZE, Ratingen, Germany. Börger V; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Fischer JC; Institute for Transplantation Diagnostics and Cell Therapeutics, University Hospital Düsseldorf, Düsseldorf, Germany. Heinold A; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Jiménez Klingberg C; German Red Cross Blood Service West, Hagen, Breitscheid, Münster and Bad-Salzuflen, Germany. Lenz V; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Riebschläger S; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Zeiler T; German Red Cross Blood Service West, Hagen, Breitscheid, Münster and Bad-Salzuflen, Germany. Horn PA; Institute for Transfusion Medicine, University Hospital, University Medicine Essen, Germany. Kordelas L; Westdeutsche SpenderZentrale WSZE, Ratingen, Germany; Clinic for Hematology and Stem Cell Transplantation, University Medicine Essen, Essen, Germany.
Pokaż więcej
Źródło:
Transplant immunology [Transpl Immunol] 2024 Feb; Vol. 82, pp. 101985. Date of Electronic Publication: 2024 Jan 04.
Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
Autorzy:
Niu X; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. Wang Y; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Zhang X; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. Wang Y; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. Shao W; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. Chen L; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Yang Z; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. Peng D; Department of Neurology, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. .; Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. .; China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .
Utilizing Massively Parallel Sequencing (MPS) of Human Leukocyte Antigen (HLA) Gene Polymorphism to Assess Relatedness in Deficiency Parentage Testing.
Autorzy:
Kouniaki DI; Immunology and Histocompatibility Department, Evangelismos General Hospital, 10676 Athens, Greece. Fotopoulos KV; School of Electrical and Computer Engineering, National Technical University of Athens (ECE-NTUA), 15772 Zografou, Greece. Tarassi K; Immunology and Histocompatibility Department, Evangelismos General Hospital, 10676 Athens, Greece. Tsirogianni A; Immunology and Histocompatibility Department, Evangelismos General Hospital, 10676 Athens, Greece.
Pokaż więcej
Źródło:
Genes [Genes (Basel)] 2024 Jan 24; Vol. 15 (2). Date of Electronic Publication: 2024 Jan 24.
A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential 'culprit' for the tramadol 'abuse crisis'.
Autorzy:
Thomford NE; Department of Medical Biochemistry, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana. .; Pharmacogenomics and Genomic Medicine Group, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana. .; Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa. . Abraham SA; Department of Adult Health, School of Nursing and Midwifery, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana. Nyarko SB; Department of Medical Biochemistry, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.; Pharmacogenomics and Genomic Medicine Group, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana. Biney RP; Pharmacogenomics and Genomic Medicine Group, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.; Department of Pharmacotherapeutics and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Jan 22; Vol. 17 (1), pp. 28. Date of Electronic Publication: 2024 Jan 22.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies